People with thoracic cancers are at higher risk of death from COVID-19 with one in three dying, according to the latest data from the international TERAVOLT registry. Presenting an update of COVID-19 outcomes for 1053 patients with a range of lung cancers at ERS 2020, Professor Jan van Meerbeeck, Head of Department of Pulmonology, Antwerp ...
Lung cancer patients with COVID-19 have 36% mortality rate: TERAVOLT
By Michael Woodhead
10 Sep 2020